In a move that would prevent MNCs such as GlaxoSmithKline (GSK), Eli Lilly, Roche and Pfizer from selling their drugs at a huge premium in India, the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes, arthritis, obesity, cancer and heart diseases.
India to have online process for clinical trials by 2013 In order to improve the process of clinical trail approvals, […]
The government has begun speeding up approvals in the area of clinical research which is set to boom in India, say top industry sources.
Considering the growth of the Indian pharma industry, the government has finally issued a notification for setting up a separate department of pharmaceuticals. The notification was issued on July 1.
